Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:22 AM
Ignite Modification Date:
2025-12-25 @ 12:22 AM
NCT ID:
NCT00806858
Eligibility Criteria:
Inclusion Criteria:
* Any subject with Type 1 or Type 2 diabetes and accepting to use NovoPen® 4. The selection will be at the discretion of the individual physician.
* A study specific signed informed consent must be signed by each subject before any study-related activities or information is collected, if required by local regulations
Exclusion Criteria:
* Subjects who are unlikely to comply with the protocol, e.g., unwillingness to cooperate, inability to return for the final visit
* Subjects with known or suspected allergy to any insulin or any of its excipients
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT00806858
Study Brief:
Protocol Section:
NCT00806858